Clinical Trials on Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)

Total 2006 results

ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Recruiting

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (COVERAGE-A)

Covid19 | SARS-CoV2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Covid19 Drug Treatment

Burkina Faso, Guinea
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
Imam Abdulrahman Bin Faisal University
Dammam Medical Complex; Institute for Research and medical consultations (IRMC)

Unknown

Antibodies Responses to COVID-19 Infection in Hospitalized Patients (No-SARS)

Hospitalized Patients | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection) | Laboratory-confirmed SARS-CoV 2 Infection

Saudi Arabia
ANRS, Emerging Infectious Diseases

Recruiting

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France, Martinique
University of Pecs
Hungarian Ministry of Innovation and Technology

Terminated

Study to Assess the Efficacy and Safety of Favipiravir-HU

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hungary
Rennes University Hospital

Unknown

Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 (ECMO-SARS)

ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2 | Acute Refractory Heart Failure Related to SARS-CoV 2

France
Cogna Technology Solutions LLC
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

United Arab Emirates
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Vanderson Geraldo Rocha

Terminated

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 (RUXO-COVID)

SARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2

Brazil
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Goethe University
Nationwide Network of University Medicine (NUM) on Covid-19

Recruiting

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) (SUEP-NAPKON)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Germany
Hospital Departamental de Villavicencio
Cooperative University of Colombia; Clinica Primavera; Clínica Meta; Grupo de Investigación...

Withdrawn

Characteristics of Patients With COVID-19 in Meta State, Colombia

SARS-CoV 2 | COVID | SARS (Severe Acute Respiratory Syndrome) | SARS (Disease) | SARS Pneumonia
AbbVie

Completed

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois (CONTACT)

Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Hôpital Universitaire Sahloul

Completed

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) (Quercetix)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | a Randomized Double-blind Study | PHYTOTHERAPIE

Tunisia
AUVA
Paracelsus Medical University

Completed

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

Coronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2

Austria
Grifols Therapeutics LLC

Terminated

A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients (COVID-19)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Spain
Inovio Pharmaceuticals
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.

Terminated

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 Disease

United States, Mexico, Colombia
National Institute of Allergy and Infectious Diseases...
PPD; University of Washington; Vanderbilt University Medical Center; Implicit Bioscience

Terminated

COVID-19 and Anti-CD14 Treatment Trial (CaTT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)

United States
BioNTech SE
Pfizer

Recruiting

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 Virus

United States, South Africa, Brazil, Puerto Rico
Gérond'if

Completed

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization (COVINUT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France
University Hospital of Ferrara

Active, not recruiting

Pro-thrombotic Status in Patients With SARS-Cov-2 Infection (ATTAC-Co)

Severe Acute Respiratory Syndrome Coronavirus 2

Italy
Rohto Pharmaceutical Co., Ltd.

Completed

An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2

Japan
Jena University Hospital

Completed

Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections (SCout)

Severe Acute Respiratory Syndrome Coronavirus 2

Germany
South African National Blood Service

Unknown

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

COVID-19 | SARS-CoV-2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2

South Africa
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Hospices Civils de Lyon

Completed

Host-pathogen Interactions During SARS-CoV-2 Infection (HPI-COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2 | Infection, Coronavirus

France
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Fred Hutchinson...

Completed

Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)

COVID-19 | Coronavirus Infection | SARS-CoV-2 Infection | SARS (Severe Acute Respiratory Syndrome)

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Influenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

COVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
A.O. Ospedale Papa Giovanni XXIII

Completed

An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications (SISCO)

Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection

Italy
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
Pfizer

Withdrawn

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 (EPIC-HOS)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Immunocompromised | Hospitalization | Child, Hospitalized

United States, Bulgaria
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
Chimerix

Terminated

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Acute Lung Injury | Coronavirus Disease 2019 (COVID-19)

United States
Hospital Universitari Joan XXIII de Tarragona.
Sociedad Española de Medicina Intensiva,critica y unidades coronarias

Recruiting

Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19) (GETCOV-2)

SARS-CoV2 Infection

Spain
Maimónides Biomedical Research Institute of Córdoba
Dynamic Solutions; Faes Farma, S.A.; Junta de Andalucía - Consejería de Salud...

Completed

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL)

SARS-CoV 2 | COVID19 | Cytokine Storm | Cytokine Release Syndrome | SARS (Severe Acute Respiratory Syndrome)

Spain
Cambridge Health Alliance
The Thoracic Foundation; Alturix

Not yet recruiting

NAC for Attenuation of COVID-19 Symptomatology (NACinCOVID2)

Covid19 | Oxidative Stress | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | COVID-19 Lower Respiratory Infection

United States
BioNTech SE

Completed

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

COVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)

United States, Germany, Turkey, South Africa
Rutgers, The State University of New Jersey
University Hospital - Newark, NJ

No longer available

Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

COVID-19 | SARS-CoV 2 | SARS-CoV Infection

United States
University of Texas Southwestern Medical Center

Terminated

Cardiovascular Implications of COVID-19

COVID-19 | SARS-CoV 2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | Cardiac Complication | SARS Pneumonia

United States
Fundação de Medicina Tropical Dr. Heitor Vieira...
Marcus Vinícius Guimarães de Lacerda; Mayla Gabriela Silva Borba; Wuelton Marcelo... and other collaborators

Completed

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
University of California, San Francisco
Rowpar Pharmaceuticals, Inc.

Terminated

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (AMPoL)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus Disease

United States
Ain Shams University
Misr International University

Completed

Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients

Corona Virus Infection | Corona Virus Disease 19 (Covid19) | Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)

Egypt
Fundação de Medicina Tropical Dr. Heitor Vieira...

Completed

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 (MetCOVID)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
Fort Worth Clinical Sciences Working Group
TCU and UNTHSC School of Medicine

Not yet recruiting

Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients (FWCSWG-IL-2)

SARS-CoV2 Infection | Cytokine Storm | SARS-CoV-2 Acute Respiratory Disease
Lahore General Hospital

Unknown

High Flow Nasal Cannula HFNC In Covid-19 Patients (HFNC19LGH)

SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Pakistan
Lahore General Hospital

Unknown

Methylprednisolone in COVID-19 Patients (Methyl19LGH) (Methyl19LGH)

SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Pakistan
Sciensano
McGill University; KU Leuven

Completed

Sero-prevalence COVID-19 Among Belgian Children (SeCoBelChild)

Covid19 | SARS-CoV-2 | SARS-CoV Infection

Belgium

Clinical Trials on Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations